Author: Benzinga Newsdesk | August 07, 2025 03:46pm
Adicet Bio (NASDAQ:ACET) reported quarterly losses of $(0.34) per share which missed the analyst consensus estimate of $(0.30) by 12.58 percent. This is a 3.03 percent decrease over losses of $(0.33) per share from the same period last year.